GCM
MRK icon

Galibier Capital Management’s Merck MRK Stock Holding History

Galibier Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17,678
Closed -$1.4M – 33
2019
Q1 		$1.4M Sell
17,678
-1,799
-9% -$135K 0.84% 27
2018
Q4 		$1.42M Buy
+19,477
New +$1.37M 0.97% 23

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Galibier Capital Management's MRK Position: Q2 2019 in Review

Galibier Capital Management sold out of Merck (MRK) in Q2 2019, closing a stake of 17,678 shares — an estimated $1.4M sold.

Galibier Capital Management first reported a position in MRK in Q4 2018 and held it in 2 quarters. The position peaked at $1.42M in Q4 2018. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

  • Galibier Capital Management reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
  • Galibier Capital Management sold 17,678 Merck shares in Q2 2019, an estimated $1.4M.
  • Galibier Capital Management first reported a position in Merck in Q4 2018 and held it in 2 quarters.
  • Galibier Capital Management's Merck position peaked at $1.42M in Q4 2018.
  • 2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Galibier Capital Management's 13F filing for Q2 2019, filed 2 Aug 2019.